By API User
‘New year, new you’ might have a nice ring to it, but instead of major transformations GPs recommend making small resolutions in 2025 to build a healthier, happier life. Every year more than 22 million Australians choose to see a GP for their essential healthcare and the RACGP is urging people to use these … Continued
By API User
EXTON, PA / ACCESSWIRE / January 6, 2025 / Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company’s leadership succession planning and that Chief Strategy Officer Dr. Wentao Zhang and President Dr. John Lin have been promoted … Continued
By API User
A major trial has found a single iron infusion in the third trimester can significantly reduce anaemia in pregnant women and outperform the efficacy of iron tablets – the current recommended standard of care. Adequate iron is critical during pregnancy to support the health of the mother and developing baby, with poor iron levels … Continued
By API User
Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+ products by year-end 2025 Pursuing two-pronged portfolio development strategy to establish strong foundation of critical injectable products while ensuring long-term competitiveness and return on investment Company to attend the 43rd Annual J.P. Morgan Healthcare Conference … Continued
By API User
NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) — Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by the Ministry of Healthand Social Security for the … Continued
By API User
Using artificial intelligence to assist in fertility treatment raises significant ethical concerns that need to be addressed, Monash University researchers have found. While machine learning tools may improve the selection of human embryos for transfer, improving the chances of a successful pregnancy and reducing the time and cost of treatments, there are myriad worries including the … Continued
By API User
Gay men who are survivors of child sexual abuse will have a supportive space to learn more about the impacts of child sexual abuse and connect with other survivors in a new trauma information group. Not Alone, a new online group, will be delivered in Victoria by experienced specialist sexual assault service counsellor advocates from … Continued
By API User
The Royal Australian College of GPs (RACGP) has welcomed the Crisafulli Government’s announcement of free influenza vaccines for all Queenslanders in 2025. RACGP Queensland Chair Dr Cathryn Hester applauded the move to continue 2024’s free vaccination program, which ensures all Queenslanders will again be able to protect themselves against the flu. “Supporting access to vaccinations … Continued
By API User
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia and Hypogammaglobulinemia Administration of Recombinant Human Hyaluronidase Prior toImmunoglobulin Facilitates Subcutaneous Infusion of Larger Volumes, Potentially Reducing Frequency and Giving Patients More Flexibility Approval Expands Takeda’s Portfolio of Differentiated Immunoglobulin Therapies … Continued
By API User
SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., announced it will change its Nasdaq ticker symbol to “ONC” on January 2, 2025, reflecting its long-standing commitment to delivering innovative oncology medicines globally. “As we enter our 15th … Continued
